Testing version — LOERadar is in active testing. Features and data may change.
VIVELLE (ESTRADIOL) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
VIVELLE
NDANot in Orange Book
ESTRADIOL | N021167 | NOVARTIS
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (5)
Sort:
#001 — 0.0375MG/24HR
▴
FILM, EXTENDED RELEASE; TRANSDERMAL | Approved: Aug. 16, 2000
No patent or exclusivity listings for this strength.
#002 — 0.05MG/24HR
▾
FILM, EXTENDED RELEASE; TRANSDERMAL | Approved: Aug. 16, 2000
#003 — 0.075MG/24HR
▾
FILM, EXTENDED RELEASE; TRANSDERMAL | Approved: Aug. 16, 2000
#004 — 0.1MG/24HR
▾
FILM, EXTENDED RELEASE; TRANSDERMAL | Approved: Aug. 16, 2000
#005 — 0.025MG/24HR
▾
FILM, EXTENDED RELEASE; TRANSDERMAL | Approved: Aug. 16, 2000